Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	103.29	80.36	39.53
Graham Fair Price	152.31	87900.32	34838.31
PEG	-97.73	< 0.005	0.09
Price/Book	6.87	0.42	0.40
Price/Cash Flow	-22.88	4.76	6.17
Prices/Earnings	-85.35	1.60	-10.95
Price/Sales	14.03	0.69	0.60
Price/FCF	-22.88	4.76	6.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-30.28	1.00	1.43
Operating Margin	-100.00	< 0.005	-2.31
ROA	581.36	< 0.005	< 0.005
ROE	< 0.005	0.07	629.41
ROIC	-0.58	< 0.005	-100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.18	0.06	199.26
Dividends QOQ	-0.25	-0.87	-241.05
EBIT QOQ	-27.23	1.00	-96.33
EPS QOQ	-1.21	7.81	544.92
FCF QOQ	-0.59	0.29	-50.03
Revenue QOQ	0.18	-0.12	-30.72
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.16	0.19	18.92
Quick Ratio	1.66	4.55	174.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	77222.86	72142.73	-6.58
Cash	15155.52	14927.78	-1.50
Capex	-85.04	-137.69	-61.90
Free Cash Flow	4961.24	6422.74	29.46
Revenue	50865.40	44533.53	-12.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.94	8.08	174.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.42	5.83	1281.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating